{
  "trial_id": "NCT02586155",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, Body Mass Index (BMI), Duration of Type 2 Diabetes Mellitus, HbA1c levels, HDL-C levels, History of Myocardial Infarction, History of Unstable Angina, Use of Diabetes Medication, Use of Statin Therapy, Blood Pressure, Renal Function (eGFR), Left Ventricular Ejection Fraction (LVEF), Smoking Status, Alcohol Use, History of Heart Failure, History of Arrhythmias, Triglyceride Levels, Liver Function Tests (ALT, AST, Total Bilirubin), History of Malignancy, Use of Immunosuppressants, Use of Fibrates or Niacin, Pregnancy Status, Compliance to Medical Regimens.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Body-mass index (BMI)",
          "Body Mass Index (BMI)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "Body weight"
      ],
      "remaining_candidate_features": [
        "Duration of Type 2 Diabetes Mellitus",
        "HbA1c levels",
        "HDL-C levels",
        "History of Myocardial Infarction",
        "History of Unstable Angina",
        "Use of Diabetes Medication",
        "Use of Statin Therapy",
        "Blood Pressure",
        "Renal Function (eGFR)",
        "Left Ventricular Ejection Fraction (LVEF)",
        "Smoking Status",
        "Alcohol Use",
        "History of Heart Failure",
        "History of Arrhythmias",
        "Triglyceride Levels",
        "Liver Function Tests (ALT, AST, Total Bilirubin)",
        "History of Malignancy",
        "Use of Immunosuppressants",
        "Use of Fibrates or Niacin",
        "Pregnancy Status",
        "Compliance to Medical Regimens"
      ]
    },
    "processed-gen-response": "Age, Gender, Body Mass Index (BMI), Duration of Type 2 Diabetes Mellitus, HbA1c levels, HDL-C levels, History of Myocardial Infarction, History of Unstable Angina, Use of Diabetes Medication, Use of Statin Therapy, Blood Pressure, Renal Function (eGFR), Left Ventricular Ejection Fraction (LVEF), Smoking Status, Alcohol Use, History of Heart Failure, History of Arrhythmias, Triglyceride Levels, Liver Function Tests (ALT, AST, Total Bilirubin), History of Malignancy, Use of Immunosuppressants, Use of Fibrates or Niacin, Pregnancy Status, Compliance to Medical Regimens."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, History of ACS event, History of myocardial infarction, Diagnosis of T2DM, HbA1c, HDL-C levels, Use of statin therapy, Blood pressure, eGFR, LVEF, Triglycerides, ALT/AST levels, Total bilirubin, History of malignancy, History of drug/alcohol abuse,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Body weight",
        "Body-mass index (BMI)"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "History of ACS event",
        "History of myocardial infarction",
        "Diagnosis of T2DM",
        "HbA1c",
        "HDL-C levels",
        "Use of statin therapy",
        "Blood pressure",
        "eGFR",
        "LVEF",
        "Triglycerides",
        "ALT/AST levels",
        "Total bilirubin",
        "History of malignancy",
        "History of drug/alcohol abuse"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, History of ACS event, History of myocardial infarction, Diagnosis of T2DM, HbA1c, HDL-C levels, Use of statin therapy, Blood pressure, eGFR, LVEF, Triglycerides, ALT/AST levels, Total bilirubin, History of malignancy, History of drug/alcohol abuse"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Male, Female, Race/Ethnicity, Customized, Region of Enrollment, History of Acute Coronary Syndrome, History of Myocardial Infarction, History of Unstable Angina, History of Coronary Artery Disease, History of Type 2 Diabetes Mellitus, HbA1c, HDL-C, LDL-C, Triglycerides, Systolic Blood Pressure, Diastolic Blood Pressure, Body Mass Index, eGFR, Left Ventricular Ejection Fraction.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Female"
        ],
        [
          "Male",
          "Sex: Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Body-mass index (BMI)",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [
        "Body weight"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "History of Acute Coronary Syndrome",
        "History of Myocardial Infarction",
        "History of Unstable Angina",
        "History of Coronary Artery Disease",
        "History of Type 2 Diabetes Mellitus",
        "HbA1c",
        "HDL-C",
        "LDL-C",
        "Triglycerides",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "eGFR",
        "Left Ventricular Ejection Fraction"
      ]
    },
    "processed-gen-response": "Age, Sex: Male, Female, Race/Ethnicity, Region of Enrollment, History of Acute Coronary Syndrome, History of Myocardial Infarction, History of Unstable Angina, History of Coronary Artery Disease, History of Type 2 Diabetes Mellitus, HbA1c, HDL-C, LDL-C, Triglycerides, Systolic Blood Pressure, Diastolic Blood Pressure, Body Mass Index, eGFR, Left Ventricular Ejection Fraction."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), systolic blood pressure, diastolic blood pressure, heart rate, history of smoking, history of hypertension, history of hyperlipidemia, history of myocardial infarction, history of coronary artery disease, history of type 2 diabetes mellitus, HbA1c, HDL-C, LDL-C, triglycerides, creatinine, eGFR, left ventricular ejection fraction (LVEF), use of medications (e.g., statins, beta blockers, ACE inhibitors, ARBs), prior coronary revascularization, prior PCI, prior CABG.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Body-mass index (BMI)",
          "body mass index (BMI)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Body weight"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "systolic blood pressure",
        "diastolic blood pressure",
        "heart rate",
        "history of smoking",
        "history of hypertension",
        "history of hyperlipidemia",
        "history of myocardial infarction",
        "history of coronary artery disease",
        "history of type 2 diabetes mellitus",
        "HbA1c",
        "HDL-C",
        "LDL-C",
        "triglycerides",
        "creatinine",
        "eGFR",
        "left ventricular ejection fraction (LVEF)",
        "use of medications (e.g., statins, beta blockers, ACE inhibitors, ARBs)",
        "prior coronary revascularization",
        "prior PCI",
        "prior CABG"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), systolic blood pressure, diastolic blood pressure, heart rate, history of smoking, history of hypertension, history of hyperlipidemia, history of myocardial infarction, history of coronary artery disease, history of type 2 diabetes mellitus, HbA1c, HDL-C, LDL-C, triglycerides, creatinine, eGFR, left ventricular ejection fraction (LVEF), use of medications (e.g., statins, beta blockers, ACE inhibitors, ARBs), prior coronary revascularization, prior PCI, prior CABG."
  }
}